ADME investigations of novel therapeutic modalities: challenges and opportunities 2025

View at publisher Summarise with VIRAT
Authors: Hongbin Yu, Richard Dambra, Gary Chan, Elise Ishida, Ali Khalilimeybodi, Nicholas Krebs, Minu Pilvankar, Swen Seeland
Cited by: 0
References: 196

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Advancements in absorption, distribution, metabolism, and excretion (ADME) science and pharmacokinetics (PK) have reshaped the drug development landscape, markedly reducing clinical attrition due to unfavorable PK properties. As biotherapeutics become increasingly complex, dose optimization has emerged as a critical focus area to address remaining translation challenges, requiring comprehensive understanding and predictability of a drug candidate's PK and its relationships with pharmacodynamic (PD) effects. AREAS COVERED: Emerging biotherapeutic modalities such as antibody-drug conjugates (ADCs), blood-brain barrier-penetrating bispecific antibodies, adeno-associated virus (AAV) gene therapy, and oncolytic viruses (OVs) present unique challenges for ADME and PK investigations given their complex composition and the dynamic biological processes governing their disposition. This review explores the distinctive ADME characteristics of these four modalities, highlighting challenges they pose to traditional PK paradigms and innovative strategies being developed to enhance preclinical-to-clinical translation. Literature search for this review was performed via PubMed database search between 30 September 2025 and 6 February 2026. EXPERT OPINION: By integrating recent preclinical and clinical insights with advances in bioanalytical methods and mechanistic modeling, we present forward-looking perspectives on enabling more precise and effective dosing strategies for these complex modalities.

Fields of Study & Subjects

Biosimilars and Bioanalytical Methods Monoclonal and Polyclonal Antibodies Research Drug Transport and Resistance Mechanisms

Publication details

Journal / source
Expert Opinion on Drug Metabolism & Toxicology
Volume
22
Issue
3
Pages
181–199
Publication date
4 March 2026
Language
EN